**Core Concept**
Vincristine is a chemotherapeutic agent used in the treatment of Acute Lymphoblastic Leukemia (ALL). It is a vinca alkaloid that acts on microtubules to inhibit cell division.

**Why the Correct Answer is Right**
Vincristine binds to tubulin, the protein subunit of microtubules, and forms a stable complex that prevents the polymerization of tubulin into microtubules. This disrupts the microtubule dynamics, leading to the inhibition of mitotic spindle formation and ultimately, cell cycle arrest at the metaphase. As a result, vincristine prevents the proliferation of cancer cells, including lymphoblasts in ALL.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because vincristine does not primarily act through DNA intercalation, which is a mechanism associated with anthracyclines and anthracenediones.

**Option B:** This option is incorrect because vincristine does not primarily act through the inhibition of topoisomerase II, which is a mechanism associated with etoposide and teniposide.

**Option C:** This option is incorrect because vincristine does not primarily act through the inhibition of tyrosine kinase, which is a mechanism associated with certain targeted therapies.

**Clinical Pearl / High-Yield Fact**
Vincristine is a neurotoxic chemotherapeutic agent that can cause peripheral neuropathy as a side effect, particularly with prolonged use or high doses. This is due to the disruption of microtubule dynamics in neuronal cells, leading to axonal degeneration.

**Correct Answer:** C. Inhibition of microtubule polymerization